Dysmetabolic Circulating Tumor Cells Are Prognostic in Metastatic Breast Cancer
Circulating tumor cells (CTCs) belong to a heterogeneous pool of rare cells, and a unequivocal phenotypic definition of CTC is lacking. Here, we present a definition of metabolically-altered CTC (MBA-CTCs) as CD45-negative cells with an increased extracellular acidification rate, detected with a sin...
Main Authors: | Giulia Brisotto, Eva Biscontin, Elisabetta Rossi, Michela Bulfoni, Aigars Piruska, Simon Spazzapan, Cristina Poggiana, Riccardo Vidotto, Agostino Steffan, Alfonso Colombatti, Wilhelm T. S. Huck, Daniela Cesselli, Rita Zamarchi, Matteo Turetta, Fabio Del Ben |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-04-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/12/4/1005 |
Similar Items
-
Clinical relevance of the combined analysis of circulating tumor cells and anti-tumor T-cell immunity in metastatic breast cancer patients
by: Elena Muraro, et al.
Published: (2022-08-01) -
Assessment of the Mutational Status of NSCLC Using Hypermetabolic Circulating Tumor Cells
by: Matteo Turetta, et al.
Published: (2018-08-01) -
Droplet Detection and Sorting System in Microfluidics: A Review
by: Can Huang, et al.
Published: (2022-12-01) -
Microfluidic Device for Droplet Pairing by Combining Droplet Railing and Floating Trap Arrays
by: Margaux Duchamp, et al.
Published: (2021-09-01) -
Transport of a Micro Liquid Plug in a Gas-Phase Flow in a Microchannel
by: Yutaka Kazoe, et al.
Published: (2018-08-01)